KLK7 (Kallikrein Related Peptidase 7)

A serine protease involved in skin desquamation, inflammation, and cancer progression.

Gene Information Card

Symbol KLK7
Full Name Kallikrein Related Peptidase 7
Gene Type protein-coding
Chromosomal Location 19q13.41
NCBI Gene ID 5650 ncbi.nlm.nih.gov/gene/5650
Ensembl ID ENSG00000169035
UniProt ID P49862
OMIM ID 604438
HGNC ID 6369
Aliases SCCE, hK7, PRSS6

Description

KLK7 encodes kallikrein-related peptidase 7, a serine protease primarily expressed in the stratum corneum of the skin. It plays a key role in desquamation by degrading corneodesmosomal proteins. Dysregulation of KLK7 is associated with inflammatory skin disorders (e.g., Netherton syndrome) and several cancers, including ovarian and breast cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Netherton syndrome Loss-of-function mutations in SPINK5 lead to unopposed KLK7 activity, causing excessive proteolysis and skin barrier defects. OMIM #256500
Ovarian cancer KLK7 overexpression promotes tumor invasion and metastasis via extracellular matrix degradation. ClinVar, COSMIC
Breast cancer Elevated KLK7 expression correlates with poor prognosis and hormone receptor status. NCBI Gene, PubMed
Atopic dermatitis Increased KLK7 activity contributes to skin barrier dysfunction and inflammation. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 125.8 High
Esophagus 15.2 Medium
Cervix 8.4 Low
Prostate 3.1 Low
Breast 1.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HaCaT (keratinocytes) 45.2 High expression; used in skin barrier studies
A431 (epidermoid carcinoma) 38.7 Overexpressed relative to normal skin
MCF-7 (breast cancer) 2.1 Low expression
OVCAR-3 (ovarian cancer) 22.5 Moderate expression; associated with invasiveness
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.247G>A (p.Gly83Arg) Missense <0.01% Reduced catalytic activity; reported in Netherton syndrome
c.485C>T (p.Thr162Met) Missense 0.02% Unknown functional effect; rare population variant
c.1-?_*? (whole gene deletion) Deletion Rare Loss of function; severe skin barrier defects
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., whole gene deletion, missense variants affecting catalytic triad) impair desquamation and lead to skin barrier defects.

Gain of Function (GOF)

Gain-of-function mutations are not well-characterized; overexpression in cancer is primarily transcriptional rather than mutational.

Dominant Negative (DN)

No dominant-negative mutations reported for KLK7.

Pathways

• KEGG: hsa04610 – Complement and coagulation cascades (indirect)
• Reactome: R-HSA-1474228 – Degradation of the extracellular matrix
• Reactome: R-HSA-6809371 – Formation of the cornified envelope

Protein Summary

KLK7 (hK7) is a 253-amino-acid serine protease with a chymotrypsin-like specificity. It is synthesized as a preproenzyme and activated by proteolytic cleavage. The mature enzyme is secreted and localizes to the extracellular space, where it degrades corneodesmosomal proteins (e.g., desmoglein 1, corneodesmosin) to facilitate skin shedding. In cancer, KLK7 promotes invasion by cleaving components of the extracellular matrix and activating other proteases.

Related Products

Product name Cat.No. Species Gene ID
KLK7 Knockout HEK293 Cell Line EDJ-KQ50544 Human 5650 Details Get a Quote
KLK7 Knockout HeLa Cell Line EDJ-KQ54232 Human 5650 Details Get a Quote
KLK7 Knockout A-549 Cell Line EDJ-KQ62724 Human 5650 Details Get a Quote
KLK7 Knockout HCT 116 Cell Line EDJ-KQ71196 Human 5650 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: